Clinical trials: Warts

Common Warts (Verruca Vulgaris)

Candin for the Treatment of Common Warts

• Completed
• Age: 12 years and older
• Phase 3

The goal of this clinical trial is to compare outcome in healthy subjects 12 years of age and older with at least 3, but no more than 20, common warts (Verruca vulgaris) following treatment with Candin or placebo.

Trial name

NCT05889845

Testing

Candin, Intradermal Solution

Where

18 sites in United States

Volunteers

330 people

Sponsor

Nielsen BioSciences, Inc.